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Pulmonary arterial hypertension (PAH) is a fatal and debilitating disease if not detected and treated early (1). A right heart cath-
eterization (RHC) is required to diagnose PAH. Determining the car-
diac output (CO) is required for diagnostic purposes to calculate the 
pulmonary vascular resistance (PVR). CO is also a critical value in the 
evaluation of PAH patients (2). It is an important prognostic hemo-
dynamic parameter both in the initial evaluation of a patient and in 
follow-up. CO has also been identified in some series as an important 
prognostic factor in PAH patients. There are multiple methods to 
determine CO, but the two most commonly used are the bolus 
thermodilution (TD) and the indirect (ie, based on assumed rather 
than directly measured oxygen consumption) Fick methods. In clinical 
practice, it is not known whether the TD or the Fick method is more 
appropriate. It is also not clear whether these two methods of CO 
determinations yield consistent measurements in all patient popula-
tions referred for RHC in the current era of PAH management. Such 
possible inconsistencies may have clinical implications that are yet to 
be evaluated.
Because there is no formally recommended specific method to 
determine CO, some physicians rely mostly on the Fick method while 
others use both TD and Fick (3). The choice of CO method is largely 
based on personal preferences, anecdotal experience and unverified 
theories rather than on evidence-based studies. Very few centres use 
the direct Fick method (whereby oxygen consumption is directly 
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BACKGRound: The relationship between thermodilution and indirect 
Fick cardiac output determination methods has not been well described.  
oBJeCTIve: To describe the relationship between these two cardiac 
output determination methods in patients evaluated for pulmonary hyper-
tension and to highlight potential clinical implications.
MeTHodS: A retrospective review of charts of all adult patients who 
underwent a right heart catheterization (RHC) between January 1, 2007 
and November 10, 2010, and participated in the pulmonary hypertension 
program of the pulmonary division at an academic institution was con-
ducted. For validation, the charts of all patients who underwent RHC 
during the same period within the cardiology division were reviewed.
ReSulTS: A total of 198 patients underwent 213 RHCs, 79 (40%) of 
whom had pulmonary arterial hypertension, were included. Forty-three per 
cent of patients had >20% difference between thermodilution and Fick. 
The average difference (thermodilution − Fick ±SD) was −0.39±2.03 L/min 
(n=213; P=0.006). There was no significant difference in bias or variabil-
ity between thermodilution and Fick among patients with tricuspid 
regurgitant jet velocity (TRJ) of <3 m/s versus those with TRJ >3 m/s 
(−0.41±2.10 L/min versus −0.36±1.93 L/min, respectively; P=0.87). In a 
multivariable analysis, the thermodilution-Fick difference increased with 
age (P=0.001).
dISCuSSIon: The presence of such discrepancy in 36% of patients 
evaluated for heart failure and/or heart transplant validated the results. In 
total, 37% of the 1315 procedures (213 performed by pulmonologists and 
1102 performed by cardiologists) had a difference of >20% between ther-
modilution and Fick.
ConCluSIon: Significant discrepancy exists between thermodilution 
and indirect Fick methods. This discrepancy potentially impacts pulmo-
nary arterial hypertension prognostication and diagnosis, and is indepen-
dent of TRJ.
Key Words:  Cardiac catheterization; Fick cardiac output, Oxygen consumption; 
Pulmonary hypertension; Thermodilution; Tricuspid regurgitation
la différence entre la mesure du débit cardiaque par 
thermodilution et par le principe de Fick : des 
répercussions sur l’évaluation de l’hypertension 
pulmonaire
HISToRIQue : Il n’y a pas de bonne description de la relation entre les modes 
de détermination du débit cardiaque par thermodilution et par le principe de 
Fick indirect.
oBJeCTIF : Décrire la relation entre ces deux modes de détermination du débit 
cardiaque chez les patients faisant l’objet d’une évaluation d’hypertension pulmo-
naire et en faire ressortir les répercussions cliniques potentielles.
MÉTHodoloGIe : Les chercheurs ont procédé à une étude rétrospective des 
dossiers de tous les patients adultes qui ont subi un cathétérisme du cœur droit 
(CCD) entre le 1er janvier 2007 et le 10 novembre 2010 et qui avaient participé 
au programme d’hypertension pulmonaire de la division de pneumologie d’un 
établissement universitaire. Pour des besoins de validation, ils ont analysé les 
dossiers de tous les patients qui ont subi un CCD au sein de la division de cardi-
ologie pendant la même période.
RÉSulTATS : Au total, 198 patients ont subi 213 CCD, dont 79 (40 %) 
souffraient d’hypertension artérielle pulmonaire. Quarante-trois pour cent 
des patients présentaient une différence de plus de 20 % entre la mesure 
par thermodilutionet celle par le principe de Fick. La différence moyenne 
(thermodilution−Fick±ÉT) était de −0,39±2,03 L/min (n=213; P=0,006). Il 
n’y avait pas de différence significative de parti pris ou de variabilité entre la 
thermodilutionet le principe de Fick chez les patients dont la vélocité du jet 
de régurgitation tricuspidienne (VJT) était de moins de 3 m/s, par rapport à 
ceux dont la VJT était supérieure à 3 m/s (−0,41±2,10 L/min par rapport à 
−0,6±1,93 L/min, respectivement; P=0,87). Dans une analyse multivariable, 
la différence entre la mesure par thermodilution et celle par le principe de 
Fickaugmentait avec l’âge (P=0,001).
eXPoSÉ : La présence d’un tel écart chez 36 % des patients subissant une 
évaluation d’insuffisance cardiaque ou de greffe cardiaque a validé les résultats. 
Au total, 37 % des 1 315 interventions (213 effectuées par un pneumologue et 
1 102, par un cardiologue) présentaient une différence de plus de 20 % entre la 
mesure par thermodilutionet celle par le principe de Fick.
ConCluSIon : Il existe un écart important entre la mesure par thermodilu-
tionet celle par le principe de Fickindirect. Cet écart, indépendant de la VJT, 
peut avoir des répercussions sur le pronostic et le diagnostic d’hypertension 
artérielle pulmonaire.
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measured rather than estimated or assumed) because it is labour inten-
sive. Thus, most catheterization laboratories are not equipped or lack 
expertise to perform the direct Fick method.  
Multiple studies from the 1960s and 1970s found a strong correla-
tion between TD (iced and room temperature measurements), direct 
Fick and indirect Fick, with correlation coefficients (r) ranging from 
0.78 to 0.96 (4-6). However, more recent studies are challenging these 
traditionally accepted correlations (7,8). Our literature review found 
only a handful of small studies (<30 to 40 patients/study) that directly 
compared TD with indirect/assumed Fick (9). It is important to note 
that most of the early studies used correlation coefficients for such 
comparisons. Unfortunately, such correlations have significant limita-
tions and, thus, may be misleading in such instances (10). This may be 
due to the common misconception that strong correlation is equiva-
lent to strong agreement, which is not necessarily true. In our study, we 
used the more appropriate and accurate Bland-Altman analysis to 
compare TD and Fick (11) for a more contemporary patient popula-
tion and catheterization laboratory methodologies.
The present study aimed to describe the concordance between 
TD and Fick methods for CO determination using contemporary 
commercially available catheters, oximeters and software in a patient 
population undergoing evaluation for pulmonary hypertension under 
real-world, nonexperimental conditions. Because of the cumulative 
inaccuracies of the multiple underlying assumptions made in each of 
these methods (Appendix A), we hypothesize that TD and indirect 
Fick methods produce different data that have crucial clinical implica-
tions such as in establishing PAH diagnosis and prognosis.
MeTHodS
Study design and population
In the present retrospective cross-sectional study of medical records, 
the electronic charts of all consecutive adult patients (>18 years of 
age, regardless of sex or race) evaluated in the PAH centre at the 
University of North Carolina at Chapel Hill (UNC, North Carolina, 
USA) were reviewed. The patients were identified by reviewing the 
UNC PAH physicians’ catheterization and clinic schedules. Patients 
who were seen between January 1, 2007 and November 10, 2010, and 
underwent an RHC were included. For validation purposes, the med-
ical charts of adult patients who were evaluated by UNC cardiologists 
for heart failure or heart transplantation and underwent a RHC within 
the same time period were also reviewed. Patients whose medical rec-
ords were missing either TD or Fick CO data were excluded from the 
analysis. Data, including demographics, pertinent medical history, 
echocardiographic findings and heart catheterization measurements, 
were recorded for patients meeting the inclusion/exclusion criteria. 
The measurement techniques were standardized (Appendix B). The 
present study was approved by the Institutional Review Board at UNC 
(IRB study 09-1672) and a waiver of informed consent was granted.
Statistical analysis
Sample size estimation: Based on an estimated mean CO of 5.5 L/min 
for both TD and Fick, and with an SD of the difference between meas-
urements of 2.75 L/min, the sample size calculated a priori that was 
required to detect a clinically meaningful difference of 20% in CO 
measurements with a two-sided alpha of 0.025 with 90% power was 94. 
The sample size of 213 dual measurements that was available for analy-
sis well exceeded the above requirement. 
Statistical considerations: Percentages of patients with different lev-
els of discrepancy between TD and Fick (TD-Fick) were expressed as a 
percentage. The agreement between the methods was analyzed as 
described by Bland and Altman (12). Agreement was expressed as the 
mean of the differences obtained by the different methods (reflecting 
bias) ±SD unless otherwise specified. Relative precision was expressed 
as the mean of the differences ±2SD (Bland-Altman limits of agree-
ment). Additionally, Pearson’s correlation coefficient was calculated 
for comparative purposes and a multiple linear regression model was 
constructed. All variables in the linear regression model were chosen 
before data collection. Based on a sample size of 213 measurements 
and to ensure the stability of the regression model, only 10 variables 
were allowed into the initial model. Interaction assessment between 
different variables in the regression model was performed first before 
checking for significant associations between the different variables 
and the outcome (ie, TD – Fick difference). Variables that were not 
statistically significant in the initial model (ie, P>0.05) were dropped 
from the model after confirming with a partial F test (also with 
P>0.05).  
The Student’s paired t test or the Wilcoxon signed-rank test was used 
as appropriate to compare TD and Fick within each group of patients. 
The Student’s t test was used to compare the CO differences between 
different subgroups of patients. A two-sided alpha of 0.025 was con-
sidered to be statistically significant for all tests without correcting for 
multiple testing, except as noted above. All statistical analyses were 
performed using STATA version 11 IC (Stata Corp, USA) for 
Windows (Microsoft Corporation, USA).
ReSulTS
Study population
Data on 256 RHC measurements in the PAH program were available. 
One set was excluded because the patient was <18 years of age. TD 
data were missing for 37 patients, Fick data were missing in two 
patients, and three other patients had both TD and Fick data missing. 
Therefore, the final study PAH program population was 213 RHC 
measurements in 198 patients (Table 1). Twelve patients underwent 
RHC twice and one patient underwent RHC four times. These RHC 
data were entered as separate data points because a sensitivity analysis 
Table 1
Patient demographics, characteristics, hemodynamic data 
and comorbidities (n=198)
PaH (n=79) Non-PaH (n=119)
Sex, n
   Female 46 85
   Male 33 34
Race, n
   African American 23 44
   Caucasian 50 68
Age, years 54±13 54±14
Body mass index, kg/m2 30.1±6.8 29.8±8.9
mPAP, mmHg 40.4±12.8* 21.7±10.0†
LVEF, % 59±7 60±6
PCWP, mmHg 13±5 12±8
Thermodilution CO, L/min 5.40±1.99 5.57±1.99
Fick CO, L/min 5.67±2.05 6.05±2.48
PVR, Wood units 6.01±4.01* 1.92±1.00
Hemoglobin, g/L 127±22.2 120±20
Different etiologies, n (%)
   Rheumatological 22 (28) 25 (21)
   Obstructive sleep apnea 11 (14) 25 (21)
   COPD 20 (25) 11 (9)
   Sarcoidosis 7 (9) 16 (13)
   Interstitial lung disease 15 (19) 8 (7)
   Liver cirrhosis 12 (15) 9 (8)
   Venous thromboembolic disease 8 (10) 5 (4)
Data presented as mean ± SD unless otherwise indicated. *Seven patients had 
mPAP <25 mmHg due to therapy and, thus, low pulmonary vascular resistance 
(PVR); †Thirty-one patients had mPAP >25 mmHg due to pulmonary venous 
hypertension (WHO group 2). CO Cardiac output; COPD Chronic obstructive 
pulmonary disease; LVEF Left ventricular ejection fraction; mPAP Mean pulmo-
nary artery pressure; PAH Pulmonary arterial hypertension; PCWP Pulmonary 
capillary wedge pressure   
TD versus Fick CO in PaH evaluation
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using only the first measurement among those with multiple measure-
ments did not change the results. Most of the RHCs were performed in 
an outpatient setting. Of the 213 observations (ie, procedures) 
included, 91 had PAH (as defined by an explicit PAH diagnosis in 
the patient’s medical chart per the clinician’s assessment and subse-
quent initiation of PAH-specific therapy based on the RHC results) 
and 93 had an estimated tricuspid regurgitation jet velocity (TRJ) of 
>3 m/s on echocardiography.
Data on 2629 RHC measurements in the cardiology programs were 
available. One data set was excluded because the patient was <18 years 
of age. TD data were missing in 863 patients, Fick data were missing in 
146 patients, 513 were cardiac procedures (such as cardiac biopsy) but 
without hemodynamic measurements and four were excluded because 
of duplicate reports. Therefore, the final study cardiology population 
was 1102 procedures in 774 patients (of which 384 were procedures in 
99 patients who underwent a heart transplant).
Td versus Fick Co measurements
PAH program population: In the PAH program population, 68% of 
procedures had a difference of ≥10% between TD and Fick, and 43% of 
procedures had a difference of ≥20%. The bias was −0.39 L/min and the 
limits of agreement were between −4.44 L/min and +3.66 L/min for the 
group as a whole between TD and Fick using the Bland-Altman analysis 
for repeated measures (n=213) (Figure 1). There was a nonuniform and 
nondirectional discrepancy between TD and Fick over a wide range of 
CO. The bias was similar between those with PAH versus those without 
PAH (−0.25 L/min versus −0.49 L/min, respectively [P=0.40]) (Table 2). 
The relationship between TD and Fick was nonlinear, although the 
statistical software would still generate a best-fit line for the linear 
regression model, which is shown for comparative purposes (Figure 2).
There was no significant difference in the discrepancy (bias or vari-
ability) between TD and Fick in the subgroup of patients with low 
versus high TRJ (Table 2). Using a multivariable linear regression 
model adjusted for age, sex, race, body mass index (BMI), left ventri-
cular ejection fraction, hemoglobin, PAH status and transpulmonary 
gradient, only age showed a statistically significant association with 
the difference between TD and Fick (beta coefficient= −0.03; 
P=0.001). When adjusted for the above mentioned covariables, with 
each 10 years increase in age, the difference between TD and Fick 
decreased by 0.35 L/min. A sensitivity analysis including TRJ (which 
was missing in 66 of 213 RHC measurements) in the multivariable 
analysis did not significantly change the results.
This variability was consistent over time (Figure 3). Using PVR 
>3 Wood units as a diagnostic criteria for PAH, 27 patients (13±2%) 
would have inconsistency in PAH diagnosis between TD and Fick 
(Figure 4).  
Cardiology program population: The RHCs performed by cardiolo-
gists showed a similar pattern of discrepancy, with 401 (36%) of the 
cardiology population (141 [37%] of the heart transplant population) 
having a discrepancy of >20% between TD and Fick.
When combining all of the RHCs performed by pulmonologists 
(n=213) and cardiologists (n=1102), 37% of these 1315 procedures had 
a difference of >20% between TD and Fick. The percentage of observa-
tions with >20% difference between TD and Fick was similar regardless 
of the patient population (PAH, non-PAH [in the PAH program], cardi-
ology and heart transplant populations]; P not significant).
Figure 1) Bland-Altman plot of the difference between thermodilution 
(TD) and Fick cardiac output (CO) over mean of TD and Fick CO 
Figure 2) Association of Fick versus (vs) thermodilution (TD) cardiac 
output (CO) with best-fit line, simple linear regression and Pearson’s cor-
relation (r) 
Table 2
Mean cardiac output (CO) difference between 
thermodilution and Fick CO in different subpopulations 
based on diagnosis, cardiac index status and severity of 
tricuspid regurgitation jet velocity (TRJ) (bland and altman 
method)
Mean CO  
difference*
2 SD confidence 
interval for CO  
difference
All procedures (n=213) −0.39 −4.44 to +3.66
PAH (irrespective of being on  
PAH-specific therapy) (n=91)
−0.25 −4.36 to +3.86
PAH not on PAH-specific therapy (n=62) −0.21 −4.50 to +4.08
Non-PAH (n=122) −0.49 −4.51 to +3.53
Low CI† (CI <2.5 L/min/m2) (n=75) −1.10 −4.46 to +2.26
Normal CI† (2.5< CI <4 L/min/m2) 
(n=122)
−0.17 −4.03 to +3.69
High CI† (CI >4 L/min/m2) (n=16) +1.36 −4.26 to +6.98
TRJ <3 m/s (n=120)‡ −0.41 −4.62 to +3.80
TRJ <3 m/s, excluding those with missing 
values (n=54) 
−0.39 −5.00 to +4.22
TRJ >3 m/s (n=93) −0.36 −4.23 to +3.51
TRJ >4 m/s (n=20) −0.29 −3.54 to +2.96
Number of procedures may include multiple procedures performed on the same 
patient. *Thermodilution – Fick CO (in L/min); †Cardiac index (CI) based on ther-
modilution; ‡66 patients did not have a TRJ reported on their echocardiogram, 
mostly because it was not detected. PAH Pulmonary arterial hypertension
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dISCuSSIon
To our knowledge, the present study is the largest to describe the dis-
crepancy between TD and indirect Fick CO determination methods. 
Our data show significant variation for individual patients, as indi-
cated by a high dispersion between the TD and Fick, despite moderate 
correlation as a group. CO has been identified in some series as an 
important prognostic factor in PAH patients. Our data indicate that 
the two most commonly used CO methods often differ. This individual 
variation may not be as well appreciated by the linear regression plot 
of TD versus Fick CO on first glance (Figure 2), but the Bland-Altman 
analysis is more demonstrative (Figure 1). The effect of discrepant CO 
on PVR calculation may have significant clinical implications.
The difference between these two methods of CO determination 
was comparable between the patients with PAH, without PAH, with 
cardiovascular disease, and status post-heart transplant and also 
between the RHCs performed by pulmonologists and those performed 
by cardiologists. Thus, we believe that an inherent discrepancy exists 
between TD and Fick, and that this discrepancy is independent of the 
characteristics of the population studied or the hemodynamics of the 
right heart. Age was the only variable that was associated with statis-
tical significance with the difference between TD and Fick in the PAH 
program population (PAH and non-PAH patients). The association 
between age and the difference between TD and Fick in the cardiology 
population validates our results (data not shown). 
We believe that a 20% difference between these two methods of 
CO determination is clinically meaningful. This difference cut-point 
of 20% is reasonable; for example, it could make a difference clinically 
if a measured CO is 4.5 L/min versus 3.6 L/min as far as inotrope use or 
other medications optimization. This difference has also been used in 
multiple other studies investigating agreement between different CO 
measurements (12-14). Because there is no gold standard to determine 
CO (15), our data strongly suggest that measuring CO using only one 
method might not be adequate. In view of our study design, we are not 
able to recommend one method versus the other. These data also sug-
gest that in certain patients, especially those with borderline diagnos-
tic criteria for PAH, direct measurements of oxygen consumption to 
obtain a direct Fick might be worthwhile to obtain a more valid esti-
mate of PVR.  
Based on our data, the PVR would vary significantly depending on 
which measurement was used. Such PVR variation could impact 
whether a PAH diagnosis is made. PVR variation could also impact 
prognostication and, thus, the aggressiveness of therapy, with the asso-
ciated adverse effects, at times, possibly being life threatening (16). 
PVR was part of the predictive Registry to EValuate Early And Long-
term pulmonary arterial hypertension disease management (REVEAL) 
registry PAH risk score (17) and, thus, an erroneous CO would lead to 
an erroneous PVR calculation and, thus, would impact prognostica-
tion. Other potentially relevant measures and prognostic variables, 
such as pulmonary vascular compliance (which equals stroke volume/
pulse pressure), could also be influenced by CO measure variability.
TD measurement was initially proposed by Fegler in the 1950s 
(18), and it became commercially available after the introduction of 
the pulmonary artery catheter in 1971 (19). The Fick measurement 
was initially proposed by Adolph Fick in 1870 (20). The direct Fick 
CO measurement may be as close to the gold standard as one can get; 
it was used by Fegler to validate the TD (18). The direct Fick typically 
involves directly measuring the patient’s oxygen consumption in the 
catheterization laboratory rather than using an assumed oxygen con-
sumption index, as is the case with the indirect Fick method (21). The 
drawback to using the direct Fick CO method is that it is not practical 
to perform in most catheterization laboratories and, consequently, is 
rarely used.  
In the early days of CO measurements, strong correlations were 
established between the TD and the direct Fick on one side (4-6, 
22,23), and between direct and indirect Fick on the other side with 
correlation coefficient (r) values >0.9 (24). However, few studies have 
directly compared TD with indirect Fick measurements. Those early 
studies with small numbers of patients (average sample size n=25 to 
n=35 patients) showed a strong correlation between TD and Fick as a 
whole group. The evidence of intra-individual correlation or concord-
ance is lacking.  
Multiple theories exist regarding the appropriateness of TD or Fick 
in certain populations. The published data overall have been conflict-
ing (25,26). A few small studies (combined n=78) consistently showed 
that TD overestimated CO in low CO states (27). These data intro-
duced the possibility of a systematic difference between these two 
methods in low CO states. On the other hand, other evidence showed 
strong correlations between TD and Fick, even in low CO patients 
(n=33) (22). One possible reason for the difference between our 
results and these studies is that the body surface area may not track 
assumed oxygen uptake above the normal BMI range. The average 
BMI of our cohort was almost 30 kg/m2. The average BMI of the 
patients in most of the published studies comparing TD and Fick has 
not been provided. With the significant increase in obesity and 
Figure 3) Variability in the difference between thermodilution and Fick 
cardiac outout over time (n=213 measurements). CO Cardiac output; 
RHC year: year that the right heart catheterization (RHC) was performed 
Figure 4) Discrepancy in pulmonary vascular resistance (PVR) based on 
thermodilution (TD) versus PVR based on Fick cardiac output (CO) 
(n=213 patients/measurements in the pulmonary arterial hypertension pro-
gram population)
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overweight prevalence in the United States in the past 30 years (28), 
our cohort – whose BMI tracks the current national average – may not 
be comparable with older cohorts. In addition, more than two-thirds of 
our patients were women, which may also not be comparable with 
older studies.  
Our findings, showing lack of effect of TRJ severity on the discrep-
ancy between TD and Fick, are similar to previous smaller studies 
(22,29,30), but different from others (25,31), suggesting ongoing con-
troversy, which may be resolved by larger future studies.  
Limitations of our study include obtaining only one Fick measure-
ment rather than checking multiple mixed venous oxygen saturations 
and averaging them out, as is the case with TD measurements. 
However, obtaining only one Fick CO measurement better reflects 
real-world practice. This being a single-centre study limits the gener-
alizability of our findings, although commonly accepted standard pro-
cedures and meticulous techniques were followed. Another potential 
limitation is that the curve for TD was not available for our review. We 
based the numbers on the RHC report. Typically, the curve is reviewed 
in real time on a video monitor, not as a hard copy that could be 
reviewed at a later time. The 37 patients who were missing TD measure-
ments and thus were excluded from the analysis could, in theory, be differ-
ent, in some way, from the rest of the study population. Unfortunately, a 
proper and informative sensitivity analysis to address this possibility 
could not be performed in view of the retrospective nature of the 
present study. One potential systemic difference could be that this 
group of patients had worse hemodynamics and, thus, a special and 
‘stiffer’ pulmonary artery catheter that lacks TD measurement equip-
ment was used. Because the pulmonologists performing these proced-
ures followed a standardized protocol for measuring both the TD and 
the Fick in all patients, this should, in principle, remove the subjectiv-
ity from the equation in ‘selecting’ patients to perform either of the 
two CO methods on.
There was not a consistent evaluation for potential cardiac or 
pulmonary shunts; however, we do not expect this to be a major 
contributor to the discrepancy we observed in this population (32), 
especially in the absence of a consistent directionality of the discrep-
ancy. The original studies identifying tricuspid regurgitation as 
impacting TD were based on the volume of the tricuspid regurgita-
tion, while echocardiographic velocity is a marker of pulmonary 
pressures and not amount of tricuspid regurgitation. We included 
TRJ and not tricuspid regurgitation volume in our analysis because 
we expected a significant amount of subjectivity in the reported 
assessment of the tricuspid regurgitation volume, especially in the 
setting of a retrospective study.
Some might also consider that there are enough convincing data 
already available in the literature that strongly suggest that TD and 
indirect Fick have a relatively good correlation if properly performed. 
However, we believe that ‘group’ correlation between these two meth-
ods is inappropriate and may yield a false sense of individual patient 
correlation (11). In addition, many studies in the literature appropri-
ately used direct Fick for comparison with either TD or indirect Fick 
CO, and clinicians have assumed that by substitution, contemporary 
indirect Fick and TD would be equivalent, which as our data show, is 
not necessarily true.
The commercialization of multiple CO measurement devices 
and the current trend of noninvasive measurements have introduced 
even more variation into clinical practice. In line with the United 
States National Institute of Health’s relatively recent focus (33), 
such methods need to be validated in real-world populations rather 
than under ideal experimental conditions. We suggest that it may 
be time to return to directly measuring CO rather than relying on 
multiple layers of assumptions, at least in certain subpopulations. It 
is reassuring that the CO is not the only physiological measurement 
that we obtain during RHC on patients being evaluated for PAH. A 
significant proportion of our clinical decision making is also based on 
other measures such as right atrial pressure and central mixed venous 
oxygen saturation. 
ConCluSIon
Our study showed significant differences between TD and indirect Fick 
in individual patients being evaluated for PAH. In the absence of a gold 
standard to measure CO or definite evidence to suggest superiority of 
either of the two most commonly used methods of CO determination, 
we recommend obtaining both TD and Fick CO data. Larger studies are 
needed to further refine the subgroups that need either or both methods 
performed, and possibly identifying the subgroup of patients that may 
need to have oxygen consumption directly measured in the catheteriza-
tion laboratory to obtain a direct Fick CO.
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APPendIX A
Cardiac output determination basis and assumptions
TD determines the CO based on how fast a set amount of fluids (typ-
ically at room temperature) moves from the right atrium [injected into 
the proximal port of the pulmonary artery (PA) catheter] to the PA 
(detected by a thermo-sensor close to the tip of the distal part of the 
PA catheter). These data are entered into a computer software that 
makes a few generalized assumptions (see below) and then generates a 
CO, the TD CO. Fick CO, on the other hand, is based on the body’s 
oxygen consumption divided by the arterio-venous differential oxygen 
content (21). Oxygen consumption, in general, is based on the meta-
bolic rate, which among others, is dependent on age, sex, body surface 
area and heart rate. In real-world clinical practice, a standard oxygen 
consumption index (usually between 125 mL O2/min and 140 mL 
O2/min) is used based on a subjective estimate of the metabolic rate 
taking into consideration the above mentioned factors. The most 
commonly used value in our population was 133 mL O2/min.
Selected assumptions include the following:
The patient who is about to undergo a procedure is at his/her • 
basal state of metabolism.
The CO is at a steady state during the different CO • 
measurements. 
Lack of respiratory variation and thus lack of right ventricular • 
preload variation.
The pulse oximeter is an accurate reflection of the arterial • 
saturation.
APPendIX B
Right heart catheterization procedure and measurements
All technical aspects and methodologies for RHC and CO determina-
tions were standardized and consistently followed. Oral sedation was 
sometimes used based on clinical setting. Most RHCs performed by the 
pulmonologists had a right internal jugular venous access placed under 
real-time ultrasound guidance, while RHCs performed by the cardiolo-
gists had either a femoral venous access or jugular venous access.  
The arterial oxygen saturation was obtained via a finger oximeter. 
No blood samples were obtained from the systemic arteries for arterial 
oxygen saturation measurements (except in a small subpopulation of 
the cardiology patients who underwent a left heart catheterization at 
the same time). Venous oxygen saturation was obtained by running a 
sample from the PA via an oximeter present in the catheterization 
laboratory. Hemoglobin level was typically checked on the same day of 
the procedure and it was again simultaneously checked with the PA 
saturation in the catheterization laboratory.
PA oxygen saturation was checked first, followed by at least a triplet of 
TD measurements (with satisfactory curves) using 10 mL of normal saline 
at room temperature. Any outlier measurement (ie, not within 10% to 
15% of the other three TD measurements) was typically discarded.
Fares et al
Can Respir J Vol 19 No 4 July/August 2012266
ReFeRenCeS
1. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 
expert consensus document on pulmonary hypertension a report of 
the American College of Cardiology Foundation Task Force on 
Expert Consensus Documents and the American Heart Association 
developed in collaboration with the American College of Chest 
Physicians; American Thoracic Society, Inc; and the Pulmonary 
Hypertension Association. J Am Coll Cardiol 2009;53:1573-619.
2. D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with 
primary pulmonary hypertension. Results from a national 
prospective registry. Ann Intern Med 1991;115:343-9.
3. Esdaile B, Raobaikady R. Survey of cardiac output monitoring in 
intensive care units in England and Wales. Critical Care 
2005;9(Suppl 1):68 (Abst).
4. Baeza H, Chamorro G, Lanas F, Escobar E. [Measurement of cardiac 
output by thermodilution. Correlation with the direct Fick method 
(author’s transl).] Rev Med Chil 1978;106:784-7.
5. Hodges M, Downs JB, Mitchell LA. Thermodilution and Fick 
cardiac index determinations following cardiac surgery.  
Crit Care Med 1975;3:182-4.
6. Enghoff E, Michaelsson M, Pavek K, Sjogren S. A comparison 
between the thermal dilution method and the direct Fick and the 
dye dilution methods for cardiac output measurements in man.  
Acta Soc Med Ups 1970;75:157-70.
7. Ross RM, Toshner M, and Pepke-Zaba J.  Limitations of assumed 
Fick cardiac output measurements in pulmonary arterial 
hypertension. Am J Respir Crit Care Med 2010;181:A3381 (Abst). 
8. Fakler U, Pauli C, Hennig M, Sebening W, Hess J. Assumed oxygen 
consumption frequently results in large errors in the determination 
of cardiac output. J Thorac Cardiovasc Surg 2005;130:272-6.
9. Bergstra A, Van Den Heuvel AFM, Zijlstra F, Berger RMF, Mook GA, 
Van Veldhuisen DJ. Validation of Fick cardiac output calculated 
with assumed oxygen consumption: A study of cardiac output 
during epoprostenol administration. Neth Heart J 2004;12:208-13.
10. Brazdzionyte J, Macas A. Bland-Altman analysis as an alternative 
approach for statistical evaluation of agreement between two 
methods for measuring hemodynamics during acute myocardial 
infarction. Medicina (Kaunas) 2007;43:208-14.
11. Bland JM, Altman DG. Statistical methods for assessing agreement 
between two methods of clinical measurement. Lancet 1986;1:307-10.
12. Weinbroum AA, Biderman P, Soffer D, Klausner JM, Szold O. 
Reliability of cardiac output calculation by the fick principle and 
central venous oxygen saturation in emergency conditions.  
J Clin Monit Comput 2008;22:361-6.
13. Baylor P. Lack of agreement between thermodilution and fick 
methods in the measurement of cardiac output. J Intensive Care 
Med 2006;21:93-8.
14. Seneff MG. Comparing thermodilution and Fick cardiac outputs: 
Should I buy an edsel or a yugo? J Intensive Care Med 2006;21:99-100.
15. Chakravarthy M. Cardiac output – have we found the ‘gold 
standard’? Ann Card Anaesth 2008;11:1-2.
16. Kallen AJ, Lederman E, Balaji A, et al. Bloodstream infections in 
patients given treatment with intravenous prostanoids.  
Infect Control Hosp Epidemiol 2008;29:342-9.
17. Benza RL, Gomberg-Maitland M., Miller DP et al. The REVEAL 
risk score calculator in newly diagnosed patients with pulmonary 
arterial hypertension. Chest 2012;141:354-62.
18. Fegler G. The reliability of the thermodilution method for 
determination of the cardiac output and the blood flow in central 
veins. Q J Exp Physiol Cogn Med Sci;42:254-66.
19. Ganz W, Donoso R, Marcus HS, Forrester JS, Swan HJ. A new 
technique for measurement of cardiac output by thermodilution in 
man. Am J Cardiol 1971;27:392-6.
20. Zuntz N. Die Ernahrung des Herzens und ihre Beziehuhg zu seiner 
Arbeitsleistung. Deuthsche Medicinische Wochenschrift 
1892;6:109-11.
21. LaFarge CG, Miettinen OS. The estimation of oxygen 
consumption. Cardiovasc Res 1970;4:23-30.
22. Hoeper MM, Maier R, Tongers J, et al. Determination of cardiac 
output by the Fick method, thermodilution, and acetylene 
rebreathing in pulmonary hypertension. Am J Respir Crit Care Med 
1999;160:535-41.
23. Hillis LD, Firth BG, Winniford MD. Analysis of factors affecting 
the variability of Fick versus indicator dilution measurements of 
cardiac output. Am J Cardiol 1985;56:764-8.
24. Kendrick AH, West J, Papouchado M, Rozkovec A. Direct Fick 
cardiac output: Are assumed values of oxygen consumption 
acceptable? Eur Heart J 1988;9:337-42.
25. Cigarroa RG, Lange RA, Williams RH, Bedotto JB, Hillis LD. 
Underestimation of cardiac output by thermodilution in patients 
with tricuspid regurgitation. Am J Med 1989;86:417-20.
26. Konishi T, Nakamura Y, Morii I, Himura Y, Kumada T, Kawai C. 
Comparison of thermodilution and Fick methods for measurement 
of cardiac output in tricuspid regurgitation. Am J Cardiol 
1992;70:538-9.
27. Van Grondelle A, Ditchey RV, Groves BM, Wagner WW Jr,  
Reeves JT. Thermodilution method overestimates low cardiac 
output in humans. Am J Physiol 1983;245:H690-2.
28. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and 
trends in obesity among US adults, 1999-2008. JAMA 
2010;303:235-41.
29. Gonzalez J, Delafosse C, Fartoukh M, et al. Comparison of bedside 
measurement of cardiac output with the thermodilution method 
and the Fick method in mechanically ventilated patients.  
Crit Care Apr 2003;7:171-8.
30. Hamilton MA, Stevenson LW, Woo M, Child JS, Tillisch JH.  
Effect of tricuspid regurgitation on the reliability of the 
thermodilution cardiac output technique in congestive heart failure. 
Am J Cardiol 1989;64:945-8.
31. Kadota LT. Theory and application of thermodilution cardiac 
output measurement: A review. Heart Lung 1985;14:605-16.
32. Mekontso Dessap A, Boissier F, Leon R, et al. Prevalence and 
prognosis of shunting across patent foramen ovale during acute 
respiratory distress syndrome. Crit Care Med 2010;38:1786-92.
33. Lauer MS, Collins FS. Using science to improve the nation’s health 
system: NIH’s commitment to comparative effectiveness research. 
JAMA 2010;303:2182-3.
